Evaluation of Paclitaxel Eluting Stent vs Paclitaxel Eluting Balloon Treating Peripheral Artery Disease of the Femoral Artery

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 150 participants.

Also called NCT01728441

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 150 participants (enrolled count) (from the registry)
Sponsor
Provascular GmbH (from the registry)
Registry
  • NCT NCT01728441
Other papers using this trial's data
  • Drug-Eluting Stent Versus Drug-Coated Balloon Revascularization in Patients With Femoropopliteal Arterial Disease Journal of the American College of Cardiology, 2019-02-19 DOI, PubMed 30765033

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Belgium, Germany (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01728441. Randomized; no masking; primary purpose treatment. Start 2012-10 (registry gives no type); primary completion 2014-05 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Evaluation of Paclitaxel Eluting Stent vs Paclitaxel Eluting Balloon Treating Peripheral Artery Disease of the Femoral Artery
Condition
Peripheral Artery Disease
Intervention (Device)
Paclitaxel Eluting Stent
Intervention (Device)
Paclitaxel Eluting Balloon
Lead sponsor
Provascular GmbH (class: other)
Collaborator
William Cook Europe (class: industry)

Record details

Record id
cardio:ct-nct01728441
Content hash
46ef668fd15442dbb006719cfb4a5ee23901e0dab75867346416146066016756